Lexeo's CEO acknowledged significant progress made in 2023, ...

Moomoo AI Dec 11, 2023 06:44

Lexeo's CEO acknowledged significant progress made in 2023, credited to the successful IPO. He anticipates more clinical data from cardiovascular and Alzheimer's disease programs in 2024.

Press Release: Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

4301 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4555Followers

0Following

9956Visitors